China Health Industries Holdings, Inc. (CHHE)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 27, 2025
CHHE Revenue
China Health Industries Holdings had revenue of $87.00 in the quarter ending March 31, 2024, a decrease of -99.59%. This brings the company's revenue in the last twelve months to $95.95K, up 77.47% year-over-year. In the fiscal year ending June 30, 2023, China Health Industries Holdings had annual revenue of $111.58K with 41,689.89% growth.
Revenue (ttm)
95.95K
Revenue Growth
+77.47%
P/S Ratio
0.07
Revenue / Employee
2.91K
Employees
34
Market Cap
6.55K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 111.58K | 111.31K | 41,689.89% |
| Jun 30, 2022 | 267.00 | -6.49M | -100.00% |
| Jun 30, 2021 | 6.49M | -3.44M | -34.63% |
| Jun 30, 2020 | 9.93M | 656.50K | 7.08% |
| Jun 30, 2019 | 9.28M | 2.72M | 41.50% |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |